Hematologic and cytogenetic responses in nilotinib trials.
Stage of disease . | No of patients . | CHR, % . | MCyR, % . | CCyR, % . |
---|---|---|---|---|
Abbreviations: CHR, complete hematologic response; CCyR, complete cytogenetic response; MCyR, major cytogenetic response. | ||||
Chronic phase11 | 321 | 77 | 57 | 41 |
Accelerated phase12 | 136 | 26 | 31 | 19 |
Blast crisis13 | 136 | 11 | 40 | 29 |
Stage of disease . | No of patients . | CHR, % . | MCyR, % . | CCyR, % . |
---|---|---|---|---|
Abbreviations: CHR, complete hematologic response; CCyR, complete cytogenetic response; MCyR, major cytogenetic response. | ||||
Chronic phase11 | 321 | 77 | 57 | 41 |
Accelerated phase12 | 136 | 26 | 31 | 19 |
Blast crisis13 | 136 | 11 | 40 | 29 |